Carcinoma, Hepatocellular: all 3,251 studies
Page 27 of 33. Open to participants first (976), then studies with results posted, then the rest; newest registration first within each.
- Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior TherapyActive, not recruitingNCT02432963Phase 1
- RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCCStatus unknownNCT02426450Phase 2
- Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular CarcinomaCompletedNCT02425605Phase 2
- Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 (Erdafitinib) in Participants With Advanced Hepatocellular CarcinomaCompletedNCT02421185Phase 1/2
- Quality of Life in Patients With Hepatocellular CarcinomaStatus unknownNCT02420678
- Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT02418988Phase 2
- Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic CholangiocarcinomaTerminatedNCT02415036Phase 2
- Genetic Profiling of Liver Cancer in Patients Undergoing Liver TransplantationCompletedNCT02412579
- An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma SubjectsCompletedNCT02409524Phase 2
- Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCCWithdrawnNCT02406508Phase 2
- Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular CarcinomaStatus unknownNCT02403544Phase 1
- Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT02400788Phase 1/2
- Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver TransplantationStatus unknownNCT02399735Phase 1
- Xihuang Capsules Prevention of Recurrence in Patients With Hepatocellular Carcinoma After HepatectomyStatus unknownNCT02399033Phase 4
- Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular CarcinomaCompletedNCT02395523Not applicable
- Anti-GPC3 CAR T for Treating Patients With Advanced HCCCompletedNCT02395250Phase 1
- A Study of rSIFN-co in Subjects With Advanced Solid TumorsCompletedNCT02387307Phase 1
- 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or TransplantActive, not recruitingNCT02379377Phase 1
- Fingerprint Characterization of Advanced HCCCompletedNCT02372162
- Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian ImmigrantsCompletedNCT02366286
- Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnifeStatus unknownNCT02363218Phase 2
- A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular CarcinomaCompletedNCT02358395Phase 1
- Epidemiologic Study of Hepatocellular Carcinoma in the USCompletedNCT02358070
- A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT02354898Phase 1
- Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver FunctionCompletedNCT02352935Not applicable
- Therapeutic Effect of Ethanol-gelfoam Mixture for the Treatment of Arterioportal Shunts (APS) in Patients With HCCStatus unknownNCT02338297Phase 3
- Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the GallbladderCompletedNCT02332551Not applicable
- Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic ResectionCompletedNCT02329821
- Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver CancerTerminatedNCT02323906Phase 1
- A Trial on SBRT After Incomplete TAE or TACE Versus Exclusive TAE or TACE For Treatment of Inoperable HCCTerminatedNCT02323360Not applicable
- Primary Prevention Hepatocellular Carcinoma by MetforminTerminatedNCT02319200Phase 3
- RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health SystemCompletedNCT02312817Not applicable
- Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study)Status unknownNCT02311205Phase 2
- Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) or Portal Vein ThrombosisStatus unknownNCT02309788
- Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal LoadStatus unknownNCT02308319Phase 4
- CIRSE Registry for SIR-Spheres TherapyCompletedNCT02305459
- Chemoembolization With or Without Stereotactic Body Radiosurgery for Liver CancerWithdrawnNCT02304445Not applicable
- Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular CarcinomaTerminatedNCT02304289Phase 1
- Combine TACE and RFA Versus TACE Alone for HCC With PVTTStatus unknownNCT02301091Phase 3
- RALPPS Venus ALPPS for Hepatocellular CarcinomaStatus unknownNCT02299843Not applicable
- Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular CarcinomaStatus unknownNCT02293850Phase 1
- Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular CancerCompletedNCT02292173Phase 1
- Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT02290977Phase 2
- A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer PatientsWithdrawnNCT02289300Phase 2
- Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular CancerWithdrawnNCT02288507Phase 1
- Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative ResectionStatus unknownNCT02281266Phase 4
- A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using BiomarkersCompletedNCT02272504
- Post-marketing Surveillance of DC Bead in Patients With Hepatocellular CarcinomaCompletedNCT02269995
- Efficacy and Safety Study of TLC388 to Advanced Hepatocellular CarcinomaTerminatedNCT02267213Phase 2
- Sorafenib Plus Vitamin K1 Versus Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT02259647Not applicable
- A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular CarcinomaStatus unknownNCT02253511Phase 4
- Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular CarcinomaCompletedNCT02243384Not applicable
- Diffusion-Weighted Magnetic Resonance ImagingStatus unknownNCT02242786Phase 2
- Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT02240771Phase 2/3
- A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC)CompletedNCT02240433Phase 1
- 18F-FluoroethylCholine Positron Emission Tomography: a Promising Diagnostic Tool for Hepatocellular CarcinomaStatus unknownNCT02238769
- Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-LStatus unknownNCT02232490Phase 3
- Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular CarcinomaCompletedNCT02229071Phase 1/2
- Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular CarcinomaWithdrawnNCT02227914Phase 1/2
- SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACEActive, not recruitingNCT02221778Phase 2
- The Efficacy and Safety of Retreatment With TAI for Patients Who Showed TACE-resistant: a Randomized Controlled TrialTerminatedNCT02220088Phase 2/3
- A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular CarcinomaCompletedNCT02210182Phase 1
- Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular CarcinomaCompletedNCT02202564Phase 2
- HR Versus RFA for HCC in Patients With PHTStatus unknownNCT02192671Phase 3
- Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular CarcinomaCompletedNCT02191878Phase 1/2
- Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional StudyCompletedNCT02188901Not applicable
- Can Quantitative MRI After cTACE Help Predict Survival ?CompletedNCT02173119
- HR Versus RFA for Early Stage HCCStatus unknownNCT02169765Phase 3
- Contrast-enhanced MRI in Detecting Benign and Malignant Liver LesionsActive, not recruitingNCT02156739Not applicable
- Quantitative Real-time Ultrasound Elastography for Characterisation of Liver TumorsCompletedNCT02156700
- LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 CirrhosisCompletedNCT02151864Phase 1
- Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular CarcinomaStatus unknownNCT02150317Not applicable
- Combination Treatment for Advanced Liver CancerWithdrawnNCT02149771Phase 3
- Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker DiversityStatus unknownNCT02148562
- Portal Hypertension and Liver Resection in Patients With Hepatocellular CarcinomaStatus unknownNCT02145013
- Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid TumorsCompletedNCT02143401Phase 1
- A Pilot Study of "OncozeneTM" Microspheres for Intra-arterial Delivery of DoxorubicinCompletedNCT02141906Phase 2
- Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan CriteriaStatus unknownNCT02138981Phase 4
- Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver ResectionStatus unknownNCT02131441Not applicable
- Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1WithdrawnNCT02129322Phase 2
- Adjuvant Radiotherapy Comparing TACE for Curative HCCStatus unknownNCT02125396Phase 3
- Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular CarcinomaCompletedNCT02109146Phase 3
- Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular CarcinomaTerminatedNCT02102022Phase 1/2
- Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver CancerCompletedNCT02101593Phase 1
- TACE Study-Liver Embolization Perfusion (VGH Radiology LIU)CompletedNCT02093104
- Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver CancerCompletedNCT02089763Phase 2
- Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCCCompletedNCT02089633Phase 2
- PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary CancerCompletedNCT02088775Not applicable
- Continued Administration of G-202 for One Patient With Advanced Hepatocellular CarcinomaNo longer availableNCT02082691
- To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular CarcinomaStatus unknownNCT02074202Phase 3
- Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT02072486Not applicable
- Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by SurgeryCompletedNCT02072356Early Phase 1
- 3T MRI to Predict TACE Response of HCCStatus unknownNCT02070822
- TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver CancerWithdrawnNCT02070419Phase 2
- Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular CancerCompletedNCT02069145Phase 1
- Circulating Tumor Cell Genome in Peripheral Blood From Hepatocellular Carcinoma Patients Under RadiotherapyStatus unknownNCT02066974
- A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular CarcinomaCompletedNCT02061956
- Selection Criteria for Safe Hepatectomy for Hepatocellular CarcinomaCompletedNCT02056041
- Pretreatment MRI Predicting Outcome After Radio-frequency Ablation of HCCStatus unknownNCT02051283
- Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency AblationStatus unknownNCT02046356